Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keyvan Yousefi

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Visualized Experiments : Jove|July 10, 2018
Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial CellsWen Ding, Keyvan Yousefi, Lina A Shehadeh
Advanced Pharmaceutical Bulletin|April 29, 2016
Chromatographic Fingerprint Analysis of Marrubiin in Marrubium vulgare L. via HPTLC TechniqueKeyvan Yousefi, Sanaz Hamedeyazdan, Mohammadali Torbati, et al.
Experimental and Molecular Pathology|June 1, 2022
The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventionsMohammad Rafi Khezri, Reza Jafari, Keyvan Yousefi, et al.
Cellular and Molecular Neurobiology|January 17, 2022
The Role of ERK1/2 Pathway in the Pathophysiology of Alzheimer's Disease: An Overview and Update on New DevelopmentsMohammad Rafi Khezri, Keyvan Yousefi, Ayda Esmaeili, et al.
Molecular Neurobiology|January 10, 2022
MicroRNAs in the pathophysiology of Alzheimer's disease and Parkinson's disease: an overviewMohammad Rafi Khezri, Keyvan Yousefi, Naime Majidi Zolbanin, et al.
Cardiovascular Research|April 29, 2017
Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failureJihe Li, Keyvan Yousefi, Wen Ding, et al.
Biochemical Pharmacology|February 8, 2022
Metformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findingsMohammad Rafi Khezri, Keyvan Yousefi, Negin Mahboubi, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 10, 2021
β<sub>2</sub>-Adrenergic receptor agonism as a therapeutic strategy for kidney diseaseAli Kamiar, Keyvan Yousefi, Julian C Dunkley, et al.
Bioimpacts : BI|May 3, 2014
Marrubium vulgare L. methanolic extract inhibits inflammatory response and prevents cardiomyocyte fibrosis in isoproterenol-induced acute myocardial infarction in ratsKeyvan Yousefi, Fatemeh Fathiazad, Hamid Soraya, et al.
Lancet (London, England)|August 23, 2025
Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trialRohit Loomba, Erin Morgan, Keyvan Yousefi, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Visualized Experiments : Jove|July 10, 2018
Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial CellsWen Ding, Keyvan Yousefi, Lina A Shehadeh
Advanced Pharmaceutical Bulletin|April 29, 2016
Chromatographic Fingerprint Analysis of Marrubiin in Marrubium vulgare L. via HPTLC TechniqueKeyvan Yousefi, Sanaz Hamedeyazdan, Mohammadali Torbati, et al.
Experimental and Molecular Pathology|June 1, 2022
The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventionsMohammad Rafi Khezri, Reza Jafari, Keyvan Yousefi, et al.
Cellular and Molecular Neurobiology|January 17, 2022
The Role of ERK1/2 Pathway in the Pathophysiology of Alzheimer's Disease: An Overview and Update on New DevelopmentsMohammad Rafi Khezri, Keyvan Yousefi, Ayda Esmaeili, et al.
Molecular Neurobiology|January 10, 2022
MicroRNAs in the pathophysiology of Alzheimer's disease and Parkinson's disease: an overviewMohammad Rafi Khezri, Keyvan Yousefi, Naime Majidi Zolbanin, et al.
Cardiovascular Research|April 29, 2017
Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failureJihe Li, Keyvan Yousefi, Wen Ding, et al.
Biochemical Pharmacology|February 8, 2022
Metformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findingsMohammad Rafi Khezri, Keyvan Yousefi, Negin Mahboubi, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 10, 2021
β<sub>2</sub>-Adrenergic receptor agonism as a therapeutic strategy for kidney diseaseAli Kamiar, Keyvan Yousefi, Julian C Dunkley, et al.
Bioimpacts : BI|May 3, 2014
Marrubium vulgare L. methanolic extract inhibits inflammatory response and prevents cardiomyocyte fibrosis in isoproterenol-induced acute myocardial infarction in ratsKeyvan Yousefi, Fatemeh Fathiazad, Hamid Soraya, et al.
Lancet (London, England)|August 23, 2025
Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trialRohit Loomba, Erin Morgan, Keyvan Yousefi, et al.
Pageof 3